Vimarsana
Biggest News Aggregation in the World

Peter Pickkers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Pickkers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Pickkers Today - Breaking & Trending Today

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock - Vimarsana News

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

·         With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths worldwide·        ...

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock - Vimarsana News

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden ...

New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved ... - Vimarsana News

New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved ...

New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved ...

EQS-News: New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients - Vimarsana News

EQS-News: New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients 05.10.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. P...

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update - Vimarsana News

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update

Patient population benefitting most from enibarcimab treatment in septic shock can clearly be defined by two biomarkers, as shown by data presented todayIn the AdrenOSS-2 trial, the respective patient subgroup had a